期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
De Novo Biosynthesis of Vindoline and Catharanthine in Saccharomyces cerevisiae 被引量:1
1
作者 Di Gao Tengfei Liu +9 位作者 Jucan Gao Junhao Xu yuanwei gou Yingjia Pan Dongfang Li Cuifang Ye Ronghui Pan Lei Huang Zhinan Xu Jiazhang Lian 《BioDesign Research》 2022年第1期1-10,共10页
Vinblastine has been used clinically as one of the most potent therapeutics for the treatment of several types of cancer.However,the traditional plant extraction method suffers from unreliable supply,low abundance,and... Vinblastine has been used clinically as one of the most potent therapeutics for the treatment of several types of cancer.However,the traditional plant extraction method suffers from unreliable supply,low abundance,and extremely high cost.Here,we use synthetic biology approach to engineer Saccharomyces cerevisiae for de novo biosynthesis of vindoline and catharanthine,which can be coupled chemically or biologically to vinblastine.On the basis of a platform strain with sufficient supply of precursors and cofactors for biosynthesis,we reconstituted,debottlenecked,and optimized the biosynthetic pathways for the production of vindoline and catharanthine.The vindoline biosynthetic pathway represents one of the most complicated pathways ever reconstituted in microbial cell factories.Using shake flask fermentation,our engineered yeast strains were able to produce catharanthine and vindoline at a titer of 527.1 and 305.1μg·liter^(−1),respectively,without accumulating detectable amount of pathway intermediates.This study establishes a representative example for the production of valuable plant natural products in yeast. 展开更多
关键词 CONSTITUTE ENGINEER valuable
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部